ArticleThe Journal of experimental medicine2021

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.

Jonathan Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.